Terren Niethamer
LightNews LightNews
banner
tniethamer.bsky.social
Terren Niethamer
@tniethamer.bsky.social
370 followers 930 following 4 posts
Mom, scientist, Stadtman Investigator at NCI. Excited about 🫀endothelial cells in 🫁 lung development and regeneration. Views my own.
Posts Replies Media Videos
Reposted by Terren Niethamer
navbo.bsky.social
Join us for an interactive #NAVBO online panel! 🚀
“Ethical and Effective Use of AI,” on January 27, 2026 at 1PM ET, organized by the Growth and Enrichment Committee.
Register here 👉 members.navbo.org/ap/Events/Re...
January 22, 2026 at 4:15 PM
Reposted by Terren Niethamer
karalmckinley.bsky.social
A beautifully written piece on a terrible time

www.science.org/content/arti...
My academic job offer was rescinded. I’ll keep going—but U.S. researchers are running out of road
Despite an uncertain future, this postdoc will “keep doing the science I love while I still have a bench”
www.science.org
July 23, 2025 at 2:25 AM
Reposted by Terren Niethamer
jax.org
Scientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a single injection, a feat with profound implications for patients with neurological diseases. 🧬🧠🔬🧪
Genome Editing Corrected Rare Brain Mutations in Mice. Could It Help Fight Neurological Diseases?
Expert mouse models and genetic research at JAX drive scientific breakthroughs, ensuring precision and reliability in advancing medical discoveries.
www.jax.org
July 21, 2025 at 3:57 PM
Reposted by Terren Niethamer
ampolter.bsky.social
I am thinking a lot today about how heavy things feel in my world of faculty doing scientific research. There's the immediate chaos and panic about our ability to pay people and continue our research. But there's also a deeper grief at watching everything get bulldozed for no reason
May 15, 2025 at 2:35 AM
Reposted by Terren Niethamer
enirenberg.bsky.social
Peter Marks’s resignation letter. Everyone should read this.
Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 March 28, 2025 Sara Brenner, MD, MPH Acting Commissioner of Food and Drugs U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 Dear Dr. Brenner: It is with a heavy heart that I have decided to resign from FDA and retire from federal service as Director of the Center for Biologics Evaluation and Research effective April 5, 2025. I leave behind a staff of professionals who are undoubtedly the most devoted to protecting and promoting the public health of any group of people that I have encountered during my four decades working in the public and private sectors. I have always done my best to advocate for their well-being and I would ask that you do the same during this very difficult time during which their critical importance to the safety and security of our nation may be underappreciated. Over the past years I have been involved in enhancing the safety of our nation's blood supply, in advancing the field of cell and gene therapy, and in responding to public health emergencies. In the last of these, during the COVID-19 pandemic I had the privilege of watching the vision that I conceived for Operation Warp Speed in March 2020 in collaboration with Dr. Robert Kadlec become a reality under the leadership of HHS Secretary Azar and President Trump due to the unwavering commitment of public servants at FDA and elsewhere across the government. At FDA, the tireless efforts of staff across the agency resulted in remarkably expediting the development of vaccines against the virus, meeting the standards for quality, safety, and effectiveness expected by the American public. The vaccines undoubtedly markedly reduced morbidity and mortality from COVID-19 in the United States and elsewhere. Many of these same individuals applied learnings from the pandemic during a flawless response helping… ongoing multistate measles outbreak that is particularly severe in Texas reminds us of what happens when confidence in well-established science underlying public health and well-being is undermined. Measles, which killed more than 100,000 unvaccinated children last year in Africa and Asia owing to pneumonitis and encephalitis caused by the virus, had been eliminated from our shores. The two-dose measles, mumps, rubella vaccine regimen (MMR) using over the past decades has a remarkably favorable benefit-risk profile. The MMR vaccine is 97% or more effective in preventing measles following the two-dose series, and its safety has been remarkably well studied. Though rarely followed by a single fever-related seizure, or very rarely by allergic reactions or blood clotting disorders, the vaccine very simply does not cause autism, nor is it associated with encephalitis or death. It does, however, protect against a potential devasting consequence of prior measles infection, subacute sclerosing panencephalitis (SSPE), which is an untreatable, relentlessly progressive neurologic disorder leading to death in about 1 in 10,000 individuals infected with measles. Undermining confidence in well-established vaccines that have met the high standards for quality, safety, and effectiveness that have been in place for decades at FDA is irresponsible, detrimental to public health, and a clear danger to our nation's health, safety. and security. In the years following the pandemic, at the Center for Biologics Evaluation and Research we have applied the same unwavering commitment to public health priorities to the development of cell and gene therapies to address both hereditary and acquired rare diseases. During my tenure as Center Director we have approved 22 gene therapies, including the first gene therapy ever to be approved in the United States. However, we know that we must do better to expedite the development of treatments for those individual suffering from any one of the thousan…
March 29, 2025 at 2:29 AM
Reposted by Terren Niethamer
labonnelab.bsky.social
Dear all, Because of your help shining light on this all 15 were reinstated today. This is a huge win for science - When We Fight We Win!!!
labonnelab.bsky.social @LaBonneLaB @labonnelab.bsky.social · Mar 11
On Valentine’s day, 15 Assistant Professors at NIH who had started their research labs in the last 2 years were fired. Their scientific expertise was built over 10-12 years of training, most if not all of which was supported by NIH. The start up funds for their laboratories were paid by NIH
March 13, 2025 at 1:26 AM
tniethamer.bsky.social
It's been a whirlwind of a month for me, but I want to take a moment to say I am so excited for this paper to be out! If you are interested in how the lung responds to injury and how it regenerates (or doesn't...) please go take a look! tinyurl.com/4r4zttkv
February 24, 2025 at 9:16 PM
Reposted by Terren Niethamer
biorxiv-devbio.bsky.social
MYRF is Essential in Mesothelial Cells to Promote Lung Development and Maturation https://www.biorxiv.org/content/10.1101/2025.02.13.635155v1
February 15, 2025 at 12:31 AM
Reposted by Terren Niethamer
jwpylvanainen.bsky.social
I put together a small guide on how to get started with Fiji. Please distribute to anyone who might benefit form this! zenodo.org/records/1477... #imageanalysis #fiji #imagej #training
Image handling using Fiji - training materials
Description:This training package provides a guide to image processing and analysis using ImageJ/Fiji, an open-source software widely used in biological and medical imaging. The manual includes step-b...
zenodo.org
January 30, 2025 at 3:10 PM
tniethamer.bsky.social
Same on both counts 😂
dgonzales1990.bsky.social Daniel Gonzales @dgonzales1990.bsky.social · Nov 25
Using this Thanksgiving week to reflect** on nearly one year of being a PI ☺️

**absolutely spiral about all the work that needs to be done
November 26, 2024 at 2:46 AM
Reposted by Terren Niethamer
thomasbchadwick.bsky.social
A STAT3–STING–IFN axis controls the metastatic spread of small cell lung cancer - Nature Immunology
Here, the authors show that signal transducer and activator of transcription 3 (STAT3) has dual functions in small cell lung cancer as its deletion inhibited primary tumor growth but boosted metastati...
www.nature.com
November 23, 2024 at 7:48 AM
tniethamer.bsky.social
We are your neighbors and friends! ❤️
kejames.bsky.social Karen James @kejames.bsky.social · Nov 17
Gift link to a nice piece in WaPo describing who federal government workers are and what they do. Spoiler: they are our neighbors and they help us. wapo.st/48W5fc5
Opinion | Government is a VA doctor. A scam buster. Your local mail carrier.
The Post is exploring “Who is government?” Our readers have a clear idea.
wapo.st
November 17, 2024 at 3:38 PM
Reposted by Terren Niethamer
biorxiv-cancer.bsky.social
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer https://www.biorxiv.org/content/10.1101/2024.11.13.623500v1
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer https://www.biorxiv.org/content/10.1101/2024.11.13.623500v1
Neuroendocrine and tuft cells are rare, chemosensory epithelial lineages defined by expression of AS
www.biorxiv.org
November 15, 2024 at 11:49 PM
Reposted by Terren Niethamer
geunsmeyer.bsky.social
Strong receptor-ligand binding affinity
#ChemistsWhoCook
A close-up view of freshly-cooked shell pasta (Annie's white mac & cheese) with green peas (previously frozen). There are a smaller number of peas than shells, but each is nestled snuggly in a shell as if purposely stuffed
November 13, 2024 at 4:59 AM
Reposted by Terren Niethamer
mjafreeman.bsky.social
Waves of new BlueSky arrivals in last few days!

I’ve been tracking starter packs relevant to molecular/mechanistic/genetic/cellular…etc biology

Hope it’s helpful but warning: now a v long thread!

Probably the last time I can do this...
November 12, 2024 at 3:03 PM
tniethamer.bsky.social
Hello BlueSky! I'm a #newpi in #devbio at #NCI interested in how endothelial cells in blood vessels help build and repair tissues - can't wait to talk science with you all! 🫀🫁
November 13, 2024 at 3:21 AM